Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06625684
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to find out what factors affect the health and risks in adults with glioblastoma (GBM), a grade 4 brain cancer. The main questions it aims to answer are: * How do genetic and immune system factors impact survival and quality of life in GBM patients? * What occupational and medical history factors are linked to the risk of getting GBM? Participants will: * Fill out an online survey about their medical history and lifestyle. Participants will have the chance to give a blood sample (from the outer arm) for genetic and immune system testing. Blood samples will be given using a home collection kit provided by the study team.
Key Dates
- Start date
- Dec 10, 2024
- Status verified
- Jan 2026
- Primary completion
- Dec 10, 2029
- Completion
- Dec 10, 2029
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Adults with GlioblastomaThis group consists of adults diagnosed with glioblastoma, a type of aggressive brain tumor. Participants are observed to identify factors influencing their outcomes, including genetic, immunologic, and personal medical history factors. The study aims to explore how these factors impact survival rates and quality of life in this patient population. There are no specific interventions. Instead, the focus is on analyzing survey data and biological samples to understand risk factors and disease progression.
Primary Outcome Measure
Overall Survival [ Time Frame: From date of enrollment until date of death from any cause as submitted by caregiver, up to 60 months ]
Central Contacts
- Quinn Ostrom, PhD919 -684-5301
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University | Durham | North Carolina | 27710 | Quinn Ostrom, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Durham, NC
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPHASE2/PHASE3 · Recruiting · Global Coalition for Adaptive Research · Birmingham, Alabama
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPHASE1 · Recruiting · Sabine Mueller, MD, PhD · Birmingham, Alabama
- Targeted Pediatric High-Grade Glioma TherapyRecruiting · Nationwide Children's Hospital · Aurora, Colorado